Production (Stage)
CardioComm Solutions, Inc.
EKG.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 121.70K | 102.70K | 72.50K | 86.80K | 128.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 121.70K | 102.70K | 72.50K | 86.80K | 128.60K |
| Cost of Revenue | 10.40K | 400.00 | 1.40K | 1.40K | 19.30K |
| Gross Profit | 111.30K | 102.30K | 71.10K | 85.40K | 109.30K |
| SG&A Expenses | 120.40K | 125.70K | 125.90K | 145.10K | 181.00K |
| Depreciation & Amortization | 5.60K | 5.20K | 5.10K | 5.20K | 3.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 136.40K | 131.30K | 132.40K | 151.70K | 204.20K |
| Operating Income | -14.70K | -28.60K | -59.90K | -64.90K | -75.60K |
| Income Before Tax | -66.20K | -56.80K | -51.10K | 33.70K | -63.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -66.20K | -56.80K | -51.10K | 33.70K | -63.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -66.20K | -56.80K | -51.10K | 33.70K | -63.80K |
| EBIT | -14.70K | -28.60K | -59.90K | -64.90K | -75.60K |
| EBITDA | -13.70K | -28.20K | -59.50K | -64.50K | -75.20K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 193.23M | 188.97M | 151.16M | 151.16M | 151.20M |
| Average Diluted Shares Outstanding | 193.23M | 188.97M | 151.16M | 151.16M | 151.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |